PMS-NILOTINIB DIN 02564947
Status: Approved
Holder: PHARMASCIENCE INC
Health Canada record
| Active ingredient(s) | NILOTINIB (NILOTINIB HYDROCHLORIDE DIHYDRATE) 150 MG |
|---|
| Dosage form | Capsule |
|---|
| Route | Oral |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Human |
|---|
| ATC | L01EA03 NILOTINIB |
|---|
| Original market date | |
|---|
| Current status date | 02-Feb-2026 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Pharmascience Inc. — licence 100241, currently licensed, last inspection rating C (2025-03-20).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing NILOTINIB (NILOTINIB HYDROCHLORIDE DIHYDRATE)
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02565005 | PMS-NILOTINIB | PHARMASCIENCE INC | Capsule | NILOTINIB (NILOTINIB HYDROCHLORIDE DIHYDRATE) 200 MG | Approved |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 36816 | 2026-02-02 | Abbreviated New Drug Submission (ANDS) | |
Request a quote for PMS-NILOTINIB
How to read a Canadian DIN record